News
She is also a Certified Stress Management Coach. The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes.
Dexcom launched the Stelo over-the-counter CGM and announced that the 15-day G7 system, cleared by the FDA, will be launched in the second half of 2025. The new system is expected to offer ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410304660/en/ Dexcom G7 15 Day is now cleared in the ...
Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
the Dexcom G7 (more on this later). Having used a total of five different CGMs, I’ve noticed the key information that matters to long-term diabetes care, and while the Dexcom Stelo — and ...
Apple Watches are more than just feature-packed wearables; they're important tools for monitoring our health, including our heart rate, sleep patterns, and cardio fitness. Even if you don't know ...
The Dexcom G7 15 Day builds on the existing Dexcom CGM technology, which has been clinically demonstrated to improve diabetes management by lowering A1C levels and reducing the occurrence of both ...
announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...
Dexcom reaffirmed its 2025 revenue guidance of ... with evident confidence in key initiatives like the 15-day G7 launch. Revenue growth accelerated to 14% in Q1 2025 from 8% in Q4 2024.
In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results